Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (661-670 of 692) with videos related to

Pageof 70
Sort By:
The New England Journal of Medicine|December 12, 2012
Abiraterone in metastatic prostate cancer without previous chemotherapyCharles J Ryan, Matthew R Smith, Johann S de Bono, et al.
Open Forum Infectious Diseases|December 22, 2023
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort StudyStephanie A Richard, Ann I Scher, Jennifer Rusiecki, et al.
Genome Medicine|June 1, 2021
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patientsDana W Y Tsui, Michael L Cheng, Maha Shady, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical TrialDeaglan McHugh, Matthew Dallos, Min Yuen Teo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
The Journal of Infectious Diseases|June 25, 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelaeNusrat J Epsi, Josh G Chenoweth, Paul W Blair, et al.
The New England Journal of Medicine|July 20, 2016
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate CancerColin C Pritchard, Joaquin Mateo, Michael F Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2Alan H Bryce, E David Crawford, Neeraj Agarwal, et al.
The Journal of Clinical Investigation|November 1, 2022
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G Zhao, Jamie M Sperger, Jennifer L Schehr, et al.
Pageof 70

Showing results (661-670 of 692) with videos related to

Sort By:
Pageof 70
The New England Journal of Medicine|December 12, 2012
Abiraterone in metastatic prostate cancer without previous chemotherapyCharles J Ryan, Matthew R Smith, Johann S de Bono, et al.
Open Forum Infectious Diseases|December 22, 2023
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort StudyStephanie A Richard, Ann I Scher, Jennifer Rusiecki, et al.
Genome Medicine|June 1, 2021
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patientsDana W Y Tsui, Michael L Cheng, Maha Shady, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical TrialDeaglan McHugh, Matthew Dallos, Min Yuen Teo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
The Journal of Infectious Diseases|June 25, 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelaeNusrat J Epsi, Josh G Chenoweth, Paul W Blair, et al.
The New England Journal of Medicine|July 20, 2016
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate CancerColin C Pritchard, Joaquin Mateo, Michael F Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2Alan H Bryce, E David Crawford, Neeraj Agarwal, et al.
The Journal of Clinical Investigation|November 1, 2022
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G Zhao, Jamie M Sperger, Jennifer L Schehr, et al.
Pageof 70